Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.11779/844
Title: Early Comparison of Major Bleeding, Stroke and Associated Medical Costs Among Treatment-Naive Non-Valvular Atrial Fibrillation Patients Initiating Apixaban, Dabigatran, Rivaroxaban or Warfarin
Authors: Alpesh, A
Keshishian, A
Xie, L
Başer, Onur
Price, K
Vo, L
Singh, P
Bruno, A
Mardekian, J
Tan, W
Singhal, S
Patel, C
Odell, K
Trocio J.
Source: Alpesh AN, Keshishian A, Xie L, Baser O, Price K, Vo L, Singh P, Bruno A, Mardekian J, Tan W, Singhal S, Patel C, Odell K, Trocio J. ( December 5-8, 2015). Early comparison of major bleeding, stroke and associated medical costs among treatment-naive non-valvular atrial fibrillation patients initiating apixaban, dabigatran, rivaroxaban or warfarin. American Society of Hematology (ASH) Annual Meeting and Exposition. Orlando. [oral presentation]
Abstract: ...
Description: Onur Başer (MEF Author)
##nofulltext##
URI: https://hdl.handle.net/20.500.11779/844
Appears in Collections:Ekonomi Bölümü Koleksiyonu

Show full item record



CORE Recommender

Page view(s)

30
checked on Nov 18, 2024

Google ScholarTM

Check





Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.